AbFero Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Abfero Pharmaceuticals, Inc
- Registration Number
- NCT03801889
- Locations
- 🇨🇦
University of Toronto- University Health Network, Toronto, Canada
🇱🇧American University of Beirut Medical Center, Beirut, Lebanon
🇹🇭Siriraj Hospital, Bangkok, Thailand
News
No news found